Product-Specific Bioequivalence

[membership level=”0,4″][The content continues for paid members only.] Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership] FDA recently updated its bioequivalence recommendations for specific products in June, adding 19 new products and making 20 revisions. The product-specific recommendations are published incrementally to assist the generics industry with identifying the most appropriate methodology for generating the therapeutic equivalence evidence needed to support ANDA approval.
[/membership]